Assessment of Cannabidiol and Δ9-Tetrahydrocannabiol in Mouse Models of Medulloblastoma and Ependymoma

SIMPLE SUMMARY: Phytocannabinoids Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) have been demonstrated to exhibit anti-cancer activity in preclinical models of brain cancer leading to new clinical trials for adults with glioblastoma. We describe here the first report that has investigated a ro...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancers (Basel)
Autors principals: Andradas, Clara, Byrne, Jacob, Kuchibhotla, Mani, Ancliffe, Mathew, Jones, Anya C., Carline, Brooke, Hii, Hilary, Truong, Alexandra, Storer, Lisa C. D., Ritzmann, Timothy A., Grundy, Richard G., Gottardo, Nicholas G., Endersby, Raelene
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7829707/
https://ncbi.nlm.nih.gov/pubmed/33477420
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13020330
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars